CLVS - Clovis Oncology

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by T0rm3nted, Apr 8, 2016.

  1. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,056
    Likes Received:
    2,929
    Clovis Oncology (CLVS) is a small pharmaceutical company which mainly markets products for treatment in oncology. Depomed was founded in 2009 and is headquartered in Dover, Colorado. The company is a publicly traded company on NASDAQ under the symbol CLVS and is in the NASDAQ Biotechnology Index with several products in its product pipeline.
     
    TomB16 likes this.
  2. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,056
    Likes Received:
    2,929
    CLVS down over 17% today.
     
  3. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,056
    Likes Received:
    2,929
    Clovis Oncology (CLVS) Approval Less Likely But Possible

    Mizuho analyst, Eric Criscuolo, thinks the FDA's briefing documents for Clovis Oncology's (NASDAQ: CLVS) April 12 rociletinib AdComm meeting raised numerous issues and concerns for the drug's approval. "It's ugly, but we think the drug could still get approved". No change to Neutral rating or $21 PT.

    The FDA voiced its displeasure over the handling of efficacy data, dose reductions, and recommends a Boxed Warning for QTc. The FDA is asking its advisory panel to vote on one question: "Should the results of the randomized clinical trial (TIGER-3) be submitted before FDA makes a regulatory decision on this application?" TIGER-3 is comparing rociletinib versus chemotherapy, potentially a 2018 event, meaning approval could be a few years away.

    The FDA highlighted a few key questions:

    1) Is the activity of rociletinib reasonably likely to predict clinical benefit and superior to available therapy?

    2) Is the recommended dose of 625 mg BID supported by the data?

    3) Are the risks (particularly QTc) acceptable?

    4) Has the dose modification strategy to been adequately characterized? FDA raised concerns about all of these areas.

    Shares of Clovis Oncology closed at $19.17 yesterday.
     
  4. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    8,539
    Likes Received:
    2,996
    Massive move and +30% close!!!

    Clovis shares jump as FDA grants priority review to cancer treatment
    http://www.marketwatch.com/story/cl...priority-review-to-cancer-tratment-2016-08-23


    Clovis Oncology Inc. CLVS, +27.24% shares ticked higher after hours Tuesday following a big jump in the regular session as the Food and Drug Administration accepted a marketing application for the company's ovarian cancer treatment and granted it a priority review process. Clovis shares advanced 1% to $23.25 after hours, following a 23% rally in the regular session. The FDA is expected to make a decision on the application by Feb. 23, 2017. Studies of Clovis's treatment rucaparib showed 54% of patients with recurring ovarian cancer responded to the treatment.
     
  5. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    8,539
    Likes Received:
    2,996
    I swear there are two biotech movers like this each day for the past week!

    Which one will run tomorrow?
     
  6. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    8,539
    Likes Received:
    2,996
    Lets see if this holds up today again.
     
  7. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    8,539
    Likes Received:
    2,996
    Big move this moring, coming up on new 52wk highs!
     
  8. LloydWCoutee

    LloydWCoutee Active Member

    Joined:
    May 4, 2016
    Messages:
    721
    Likes Received:
    58
    Credit Suisse analyst: $CLVS could be worth $35-$41 per share on operational synergies, and $52-$55 per share with leveraged tax benefits.
     
  9. Stockaholic

    Stockaholic Content Manager

    Joined:
    Mar 29, 2016
    Messages:
    13,767
    Likes Received:
    7,038
    big loser this morning -30% on the open ... coming into the daily 50sma

    [​IMG]
     
  10. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,056
    Likes Received:
    2,929
    Looks like there were some deaths in some of the patients:

    Clovis Oncology Inc (NASDAQ:CLVS) investors are heading for the hills after the cancer drug maker announced the oral presentation of the primary efficacy and safety data from its NDA dataset for rucaparib, a third-line treatment of ovarian cancer patients with BRCA-mutated tumors, at the 2016 ESMO Congress in Copenhagen. On the negative side, the company disclosed that nine patients had adverse events that led to death, of which 8 were due to disease progression.

    http://www.smarteranalyst.com/2016/...-heres-clovis-oncology-inc-shares-falling-28/
     
  11. LloydWCoutee

    LloydWCoutee Active Member

    Joined:
    May 4, 2016
    Messages:
    721
    Likes Received:
    58
    will be funny if it go green
     
  12. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,056
    Likes Received:
    2,929
    Analyst Upgrade/Downgrade Update

    Brokerage firm:
    Chardan Capital Mkts
    Change: Coverage Initiated
    Previous Rating: N/A
    Current Rating: Sell
    Previous Price Target: N/A
    Current Price Target: $15
     
  13. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    8,539
    Likes Received:
    2,996
    Big technical break out today!
     
  14. Gambit

    Gambit Active Member

    Joined:
    Oct 16, 2016
    Messages:
    703
    Likes Received:
    62
  15. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    8,539
    Likes Received:
    2,996
  16. Charles Noble

    Charles Noble Well-Known Member

    Joined:
    Jun 6, 2017
    Messages:
    204
    Likes Received:
    278
    Very predictable with no Monday BO. This will flounder a couple points here and there. The by end of week, new high. Go long for 120+
     
    TomB16, Jack Levy and fidelgeorge like this.
  17. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    8,539
    Likes Received:
    2,996
    Up and over $15
     
    TomB16 likes this.
  18. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    8,539
    Likes Received:
    2,996
    Looks like traders are putting their hopes in here, if not for some vaccine, then at least a trade
     
  19. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    8,539
    Likes Received:
    2,996
    Is this moving because of the reddit crowd?
     
  20. Rustic1

    Rustic1 Well-Known Member

    Joined:
    Jan 3, 2021
    Messages:
    1,143
    Likes Received:
    442

    :D HOKUS POKUS :cool2:
     

Share This Page